You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Patients with periprosthetic Staphylococcus infection receiving clindamycin-rifampin combination therapy

From: Clindamycin-rifampin combination therapy for staphylococcal periprosthetic joint infections: a retrospective observational study

  Debridement and retention Revision
n (%) n (%)
Number of patients 18 18
 Age, years; median (range) 71 (39 – 89) 58 (30 – 87)
 BMIa, kg/m2; median (range) 26 (20 – 32) 25 (19 – 35)
 Gender, male 12 13
Prosthesis site
 Hip 13 18
 Knee 5 0
Indication for prosthesis
 Primary arthrosis 5 3
 Secondary arthrosis
 Childhood hip disease 1 4
 Post traumatic 3 2
 Osteonecrosis 1 1
 Rheumatoid arthritis 1 0
 Hemophilia 1 0
 Revision arthroplasty 5 6
 Unknown 0 2
 Femoral neck fracture 1 0
Risk factors for PJIb / comorbidity
 Previous hip/knee surgery before primary THA/TKA 10 10
 Immune suppression 1 2
 Previous PJI 1 2
 Diabetes Mellitus 2 2
 Obesity (BMIa > 30 kg/m2) 1 3
 ASAc score; median (range) 2 (1 – 3) 2 (1 – 3)
  1. aBMI, Body Mass Index
  2. bPJI, Periprosthetic Joint Infection
  3. cASA, American Society of Anesthesiologists; THA, total hip arthroplasty; TKA, total knee arthroplasty